These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29765973)

  • 1. Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient.
    Ramot Y; Zlotogorski A
    Skin Appendage Disord; 2018 Apr; 4(2):122-124. PubMed ID: 29765973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata.
    Deeb M; Beach RA
    J Cutan Med Surg; 2017; 21(6):562-563. PubMed ID: 28635319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard.
    Forouzan P; Cohen PR
    Cureus; 2020 Jul; 12(7):e9500. PubMed ID: 32766019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
    Paggioli I; Moss J
    J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
    Bokhari L; Sinclair R
    Int J Dermatol; 2018 Dec; 57(12):1464-1470. PubMed ID: 30160787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata.
    Kołcz K; Żychowska M; Sawińska E; Reich A
    Dermatol Ther (Heidelb); 2023 Mar; 13(3):843-856. PubMed ID: 36639612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients.
    Shivanna CB; Shenoy C; Priya RA
    Int J Trichology; 2018; 10(3):103-107. PubMed ID: 30034188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
    Gupta AK; Carviel JL; Abramovits W
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1373-8. PubMed ID: 27306107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.
    Cai L; Wei Y; Zhao M; Zhuo J; Tao X; Lin M
    Front Med (Lausanne); 2023; 10():1253795. PubMed ID: 37877023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent response to tofacitinib treatment in a patient with alopecia universalis.
    Erduran F; Adışen E; Aksakal AB
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):47-49. PubMed ID: 28632888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Janus kinase inhibitors for alopecia areata.
    King BA; Craiglow BG
    J Am Acad Dermatol; 2023 Aug; 89(2S):S29-S32. PubMed ID: 37591562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe alopecia areata with baricitinib.
    Olamiju B; Friedmann A; King B
    JAAD Case Rep; 2019 Oct; 5(10):892-894. PubMed ID: 31681829
    [No Abstract]   [Full Text] [Related]  

  • 14. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
    Eisman S; Sinclair R
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis.
    Sharath S; Sardana K; Khurana A
    Indian Dermatol Online J; 2024; 15(1):49-54. PubMed ID: 38282998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.
    Mackay-Wiggan J; Jabbari A; Nguyen N; Cerise JE; Clark C; Ulerio G; Furniss M; Vaughan R; Christiano AM; Clynes R
    JCI Insight; 2016 Sep; 1(15):e89790. PubMed ID: 27699253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
    Chartaux E; Joly P
    Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report.
    Oliel S; Moussa S; Stanciu M; Netchiporouk E
    SAGE Open Med Case Rep; 2023; 11():2050313X231213135. PubMed ID: 38033914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
    Yu L; Yu H; Zhang S; Hao Y; Zhang S
    Front Immunol; 2022; 13():904156. PubMed ID: 35795663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis.
    Varghese SA; Nair SS; George AE; Yadev I
    Int J Trichology; 2023; 15(4):149-153. PubMed ID: 38765726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.